![](/img/cover-not-exists.png)
Vorinostat or placebo in combination with bortezomib in patients with multiple myeloma (VANTAGE 088): a multicentre, randomised, double-blind study
Dimopoulos, Meletios, Siegel, David S, Lonial, Sagar, Qi, Junyuan, Hajek, Roman, Facon, Thierry, Rosinol, Laura, Williams, Catherine, Blacklock, Hilary, Goldschmidt, Hartmut, Hungria, Vania, Spencer,Volume:
14
Language:
english
Journal:
The Lancet Oncology
DOI:
10.1016/S1470-2045(13)70398-X
Date:
October, 2013
File:
PDF, 290 KB
english, 2013